Cite
HARVARD Citation
Genovese, M. et al. (2013). FRI0256 Long-term safety of tocilizumab in patients with rheumatoid arthritis following a mean treatment duration of 3.9 years. Annals of the rheumatic diseases. p. A461. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Genovese, M. et al. (2013). FRI0256 Long-term safety of tocilizumab in patients with rheumatoid arthritis following a mean treatment duration of 3.9 years. Annals of the rheumatic diseases. p. A461. [Online].